Asensus Surgical, Inc. (ASXC)

NYSEAMERICAN: ASXC · IEX Real-Time Price · USD
0.417
-0.016 (-3.63%)
Jun 24, 2022 4:00 PM EDT - Market closed
-3.63%
Market Cap 98.68M
Revenue (ttm) 7.22M
Net Income (ttm) -64.25M
Shares Out 236.46M
EPS (ttm) -0.27
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 29,304,259
Open 0.446
Previous Close 0.433
Day's Range 0.400 - 0.459
52-Week Range 0.350 - 3.600
Beta 1.68
Analysts Buy
Price Target 4.08 (+877.7%)
Earnings Date Aug 4, 2022

About ASXC

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up ... [Read more...]

Industry Medical Devices
Founded 2006
CEO Anthony Fernando
Employees 153
Stock Exchange NYSEAMERICAN
Ticker Symbol ASXC
Full Company Profile

Financial Performance

In 2021, ASXC's revenue was $8.23 million, an increase of 159.28% compared to the previous year's $3.18 million. Losses were -$62.46 million, 5.31% more than in 2020.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for ASXC stock is "Buy." The 12-month stock price forecast is 4.08, which is an increase of 877.71% from the latest price.

Price Target
$4.08
(877.71% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Asensus Surgical to Participate in the H. C. Wainwright Global Investment Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate...

Asensus Surgical (ASXC) Reports Q1 Loss, Lags Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 12.50% and 18%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2022

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...

Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 4, 2022

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new er...

Investing in 60 Seconds: Asensus Surgical

Asensus Surgical is leading the digital surgical market with Performance-Guided Surgery(TM)New York, New York--(Newsfile Corp. - April 20, 2022) - PCG Digital -- Surgery can be unpredictable, and a stag...

Asensus Surgical (ASXC) Reports Q4 Loss, Tops Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0% and 7.65%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2021

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...

Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2021 Financial and Operating Results Conference Call ...

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new er...

Asensus Surgical: Reimagining the Future of Surgery

Setting a new standard with Performance-Guided SurgeryNew York, New York--(Newsfile Corp. - January 26, 2022) - -- PCG Digital-- Asensus Surgical, Inc. (NYSE American: ASXC) is leading the digital surgi...

Is This Rapidly Growing Surgical Robotics Stock a Buy?

Asensus Surgical's Senhance Surgical System is being more widely adopted by surgeons.

Asensus Surgical Provides Preliminary 2021 Year-End Corporate Update

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...

Best Penny Stocks to Buy In January 2022? 3 Investors Are Watching

Are these penny stocks on your January 2022 watchlist? The post Best Penny Stocks to Buy In January 2022?

Other symbols: ABEVACRX

Asensus Surgical to Participate in the 40th Annual J.P. Morgan Healthcare Conference and H.C.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive...

Asensus Surgical Announces Purchase of Senhance Robotic System by RZD Medicine

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...

Asensus Surgical Announces Franklin Medical Center to Initiate the Installation of the Senhance Surgical System

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...

Best Biotech Penny Stocks to Buy in November? 3 to Watch Now

Which biotech penny stocks are you watching this month? The post Best Biotech Penny Stocks to Buy in November?

Other symbols: ALZN

Why Asensus Surgical Stock Is Moving Up Today

Earnings results for the third quarter look great, until you peek under the hood.

Asensus Surgical (ASXC) Reports Q3 Loss, Tops Revenue Estimates

Asensus Surgical (ASXC) delivered earnings and revenue surprises of 0.00% and 152.06%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2021

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...

Asensus Surgical Announces Shinmatsudo Central General Hospital in Japan to Initiate Senhance Robotic Surgical System

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...

Asensus Surgical (ASXC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Asensus Surgical (ASXC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 3, 2021

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new er...

Hot Reddit Penny Stocks to Watch Right Now? Check These 3 Out

Reddit penny stocks continue to attract new investors, here's three to watch The post Hot Reddit Penny Stocks to Watch Right Now? Check These 3 Out appeared first on Penny Stocks to Buy, Picks, News and...

Other symbols: IAGMUX

7 Penny Stocks to Pick Up if You Have $100 to Spare

They're not exactly names you want to bet the ranch on. Still, a $100 position in each of these penny stocks could be worth the risk.

Asensus Surgical, Inc. Announces Hirosaki University Hospital to Initiate Senhance Robotic Surgery Program

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a ne...